Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
10
|
pubmed:dateCreated |
1997-11-5
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0046-8177
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
28
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1218
|
pubmed:dateRevised |
2005-11-17
|
pubmed:meshHeading |
pubmed-meshheading:9343333-Female,
pubmed-meshheading:9343333-Great Britain,
pubmed-meshheading:9343333-Humans,
pubmed-meshheading:9343333-Mass Screening,
pubmed-meshheading:9343333-Quality of Health Care,
pubmed-meshheading:9343333-United States,
pubmed-meshheading:9343333-Uterine Cervical Neoplasms,
pubmed-meshheading:9343333-Vaginal Smears
|
pubmed:year |
1997
|
pubmed:articleTitle |
Pap smears are financially undervalued in the United States.
|
pubmed:publicationType |
Letter,
Comment
|